Last reviewed · How we verify

NCT04826666: TOF_PHLEBO

Intraoperative Phlebotomies and Bleeding in Liver Transplantation

Completed Last updated 9 November 2021
What this trial tests

trial in Liver Diseases in 679 participants. Completed in 4 November 2021.

Timeline
31 March 2021
Primary endpoint
4 November 2021
4 November 2021

Quick facts

Lead sponsorCentre hospitalier de l'Université de Montréal (CHUM)
StatusCompleted
Study typeOBSERVATIONAL
Enrollment679
Start date31 March 2021
Primary completion4 November 2021
Estimated completion4 November 2021
Sites1 location across Canada

Conditions studied

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

Eligibility, any sex, with Liver Diseases or Liver Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Liver transplantation are surgeries associated with important bleeding and often require perioperative red blood cell (RBC) transfusions. Overall, between 20 and 85 % of liver transplant recipients receive at least one RBC transfusion during their surgery. Such transfusions are consistently associated with higher morbidity and mortality, although this causal association is still under debate in many surgical populations. Despite the lack of clear causative association between perioperative transfusions and worse outcomes, minimizing bleeding and transfusions is believed to improve postoperative outcomes. Many perioperative variables are associated with higher blood loss and need for perioperative transfusions: liver disease severity, preoperative anemia and coagulopathy, higher cardiac filling pressures and higher fluid administration, among others. However, few perioperative interventions have been shown to reduce bleeding and transfusion requirements in this population. Among them, the use of intraoperative phlebotomies to reduce portal and hepatic venous pressure during the dissection phase is a promising one, also described in liver resection surgery. To further investigate the effects of intraoperative phlebotomies on intraoperative bleeding, perioperative transfusions and mortality, the Principal Investigator will conduct a retrospective cohort study with a propensity score based causal analysis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Intraoperative phlebotomies and bleeding in liver transplantation: a historical cohort study and causal analysis.
    Carrier FM, Ferreira Guerra S, Coulombe J, Amzallag É, et al · · 2022 · cited 5× · PMID 35112303 · DOI 10.1007/s12630-022-02197-1

Verify or expand the search:

Other recruiting trials for Liver Diseases

Currently open trials in the same condition.

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04826666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing